BioSpace News Archive

Drug Development

Gilead Plans NDA for Rheumatoid Arthritis Drug Filgotinib

Based on positive data from its FINCH program, Gilead aims to seek regulatory approval for its Jak inhibitor.

July 2, 2019
·
2 min read
·
Alex Keown
Business

BioSpace Global Roundup: July 3

Companies from across the globe provide information on agreements and pipeline updates.

July 2, 2019
·
5 min read
·
Alex Keown
Business

SV Health Investors announces the appointment of Jonathan Behr, PhD as Partner in the Dementia Discovery Fund

Former founding managing director of JDRF T1D Fund joins DDF leadership team

July 2, 2019
·
4 min read
Deals

Invitation to presentation of BioArctic’s Interim Report for the second quarter of 2019 on July 11 at 9.30 a.m. CET

BioArctic AB to publish the company’s Interim Report for the period January – June 2019 on Thursday, July 11, 2019 at 08:00 a.m. CET.

July 2, 2019
·
1 min read
Business

Oncovita signs exclusive licensing agreement with Institut Pasteur

Agreement will cover development and marketing of oncolytic virotherapies

July 2, 2019
·
3 min read
Policy

Mucosis Announces Re-issue of Major Patent by US Patent Office – USPTO – for Prevention of Respiratory Syncytial Virus

Patented technology applied in SynGEM, a needle-free nasal spray vaccine against respiratory syncytial virus * Re-Issuance of U.S. Patent No. RE 47,471 further bolsters Mucosis’ intellectual property portfolio

July 2, 2019
·
4 min read
Drug Development

Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on Phase 2 Sarcoma Trial With Monopar’s Novel Camsirubicin

Trial Designed to Test Camsirubicin Against Doxorubicin as First-Line Therapy

July 2, 2019
·
4 min read
Job Trends

UH Researcher Reports the Way Sickle Cells Form May be Key to Stopping Them

Process Could Be Similar to How First Living Cells Formed; Applications to Industry Possible

July 2, 2019
·
3 min read
Drug Development

Orion Biotechnology’s CCR5 Blocker OB-002 Shows Strong Efficacy in a New Preclinical Model of Multiple Sclerosis

Orion Biotechnology Canada Ltd. announced the publication of preclinical data evaluating the efficacy of OB-002 in a murine model of multiple sclerosis in Science Translation Medicine

July 2, 2019
·
3 min read
Drug Development

Pancreatic Cancer Update: Abandoned Trial, Exciting Research, New Appointments

Pancreatic cancer is a particularly difficult cancer to treat, and although there have been advances in treatment, it is still an extremely deadly disease. Here’s a look at some recent news concerning pancreatic cancer.

July 2, 2019
·
3 min read
·
Mark Terry